35 results on '"Ramagopalan, Sreeram"'
Search Results
2. Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis
3. Emulating Trials and Quantifying Bias: The Convergence of Health Technology Assessment Agency Real-World Evidence Guidance
4. Angiogenic factors are associated with multiple sclerosis
5. The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment
6. Concealed effects of gene–environment interactions in genome-wide association
7. Vitamin D–gene interactions in multiple sclerosis
8. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians
9. Multiple sclerosis: risk factors, prodromes, and potential causal pathways
10. Epigenetics: molecular mechanisms and implications for disease
11. No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5
12. Childhood cow's milk allergy and the risk of multiple sclerosis: A population based study
13. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis
14. The genetics of clinical outcome in multiple sclerosis
15. Autoimmune disease in families with multiple sclerosis: a population-based study
16. Sex ratio of multiple sclerosis in Canada: a longitudinal study
17. Distributional Cost-Effectiveness Analysis of Health Technologies: Data Requirements and Challenges
18. Assessment of tumour-agnostic therapies in basket trials
19. Early life child exposure and the risk of multiple sclerosis: A population based study
20. Cytomegalovirus and varicella zoster virus seropositivity of Iranian patients with multiple sclerosis: A population-based study
21. MANAGEMENT OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION FOLLOWING A FIRST CLINICALLY RELEVANT BLEED: A REAL-WORLD STUDY BASED ON UK CLINICAL PRACTICE RESEARCH DATALINK - HOSPITAL EPISODE STATISTICS DATA
22. Sequencing the multiple sclerosis genome: more questions than answers
23. IGHV4-39 deletion polymorphism does not associate with risk or outcome of multiple sclerosis
24. Can we predict multiple sclerosis?
25. Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families
26. ANTICOAGULATION CONTROL IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION TREATED WITH VITAMIN K ANTAGONIST THERAPY FOR 12 MONTHS OR MORE IN PRIMARY CARE IN THE UK
27. 25-hydroxyvitamin D levels are associated with multiple sclerosis in Iran: A cross-sectional study
28. Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis
29. Parental non-inherited HLA resistance alleles do not confer protection against multiple sclerosis
30. Genes for multiple sclerosis
31. Tuberculosis and diabetes mellitus: is vitamin D the missing link?
32. GPC5 and lung cancer in multiple sclerosis
33. The questionable effectiveness of sunscreen
34. Has neurology been demystified?
35. Clustering of autoimmune disease in families at high risk for multiple sclerosis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.